儿童重症监护输血与贫血专家倡议:危重患儿红细胞成分选择与处理的推荐
该共识由儿童重症监护输血与贫血专家倡议组织38名国际多学科专家制定,采用RAND/UCLA适宜性方法和GRADE分级,检索1980年至2017年5月PubMed、EMBASE和Cochrane Library数据库。红细胞处理亚组5名专家提出5条推荐并达成超过80%的共识。推荐包括:对严重先天性或获得性免疫缺陷或供者为血亲的患儿使用辐照细胞制品;对严重过敏反应史者使用洗涤细胞并避免其他含血浆制品;对严重过敏史者输血前评估过敏体征;对严重IgA缺乏伴抗IgA抗体和/或严重输血反应史者使用IgA缺乏供者制品和/或洗涤细胞。推荐主要基于儿童和成人病例报告数据。
要点
- 对严重先天性或获得性免疫缺陷或供者为血亲的危重患儿,推荐使用辐照细胞制品预防输血相关移植物抗宿主病。
- 对有严重过敏反应或过敏症输血史的危重患儿,推荐使用洗涤细胞血液成分并避免其他含血浆制品。
- 对有严重过敏输血史患儿,推荐输血前评估过敏体征。
- 对严重IgA缺乏伴抗IgA抗体和/或严重输血反应史者,推荐使用IgA缺乏供者制品和/或洗涤细胞成分。
- 上述推荐主要基于儿童和成人病例报告数据,共识达成率超过80%。
适用人群与场景
- 危重患儿,包括严重先天性或获得性免疫缺陷者、供者为血亲者、有严重过敏输血反应史者、严重IgA缺乏伴抗IgA抗体和/或严重输血反应史者。
处置流程与药物剂量
- 对有严重先天性或获得性免疫缺陷或供者为血亲的患儿,推荐使用辐照细胞制品。
- 对有严重过敏反应或过敏症输血史的危重患儿,推荐使用洗涤细胞血液成分并避免其他含血浆制品。
- 对有严重过敏输血反应史的患儿,推荐输血前评估过敏体征。
- 对严重IgA缺乏伴抗IgA抗体和/或严重输血反应史的患儿,推荐使用来自IgA缺乏供者的血液成分和/或洗涤细胞成分。
研究设计与关键结果
- 共识会议纳入38名国际多学科专家,红细胞处理亚组5名专家,5条推荐达成超过80%的同意。
- 证据检索范围为1980年至2017年5月,使用PubMed、EMBASE和Cochrane Library数据库,采用RAND/UCLA适宜性方法和GRADE分级。
证据类型、等级与局限
- 证据类型:国际多学科专家共识会议推荐,采用GRADE分级。
- 推荐主要基于儿童和成人病例报告数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对严重免疫缺陷或供者为血亲的危重患儿,输血时应选择辐照细胞制品。
- 对有严重过敏输血史的危重患儿,应选择洗涤细胞制品并避免其他含血浆制品,输血前评估过敏体征。
- 对严重IgA缺乏伴抗IgA抗体和/或严重输血反应史者,应选择IgA缺乏供者制品和/或洗涤细胞成分。
指南或共识出处
- Pediatric Critical Care Transfusion and Anemia Expertise Initiative共识会议推荐,发表于Pediatric Critical Care Medicine。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To present the recommendations and supporting literature for selection and processing of RBC products in critically ill children developed by the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.
DESIGN: Consensus conference series of international, multidisciplinary experts in RBC transfusion management of critically ill children METHODS:: The panel of 38 experts developed evidence-based, and when evidence was lacking, expert-based clinical recommendations as well as research priorities for RBC transfusions in critically ill children. The RBC processing subgroup included five experts. Electronic searches were conducted using PubMed, EMBASE, and Cochrane Library databases from 1980 to May 2017. Agreement was obtained using the Research and Development/UCLA Appropriateness Method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method.
RESULTS: Five recommendations reached agreement (> 80%). Irradiated cellular products are recommended for children at risk of transfusion-associated graft versus host disease due to severe congenital or acquired causes of immune deficiency or when the blood donor is a blood relative. Washed cellular blood components and avoidance of other plasma-containing products are recommended for critically ill children with history of severe allergic reactions or anaphylaxis to blood transfusions, although patient factors appear to be important in the pathogenesis of reactions. For children with history of severe allergic transfusion reactions, evaluation for allergic stigmata prior to transfusion is recommended. In children with severe immunoglobulin A deficiency with evidence of antiimmunoglobulin A antibodies and/or a history of a severe transfusion reaction, immunoglobulin A-deficient blood components obtained either from an immunoglobulin A-deficient donor and/or washed cellular components is recommended.
CONCLUSIONS: The Transfusion and Anemia Expertise Initiative consensus conference developed recommendations for selection and processing of RBC units for critically ill children. Recommendations in this area are largely based on pediatric and adult case report data.
参考来源
- Zantek ND, Parker RI, van de Watering LM, et al. Recommendations on Selection and Processing of RBC Components for Pediatric Patients From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Pediatr Crit Care Med. 2018. PMID: 30161072. doi:10.1097/PCC.0000000000001625
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。